HEADER TRANSLATION 23-FEB-11 3QTM TITLE STRUCTURE OF S. POMBE NUCLEAR IMPORT ADAPTOR NRO1 (SPACE GROUP P21) COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN C4B3.07; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 56-393; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHIZOSACCHAROMYCES POMBE; SOURCE 3 ORGANISM_COMMON: FISSION YEAST; SOURCE 4 ORGANISM_TAXID: 4896; SOURCE 5 GENE: SPCC4B3.07; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21-A KEYWDS TETRATRICOPEPTIDE REPEAT, ENHANCER OF TRANSLATION TERMINATION, KEYWDS 2 TRANSLATION EXPDTA X-RAY DIFFRACTION AUTHOR D.RISPAL,J.HENRI,H.VAN TILBEURGH,M.GRAILLE,B.SERAPHIN REVDAT 3 03-JAN-18 3QTM 1 TITLE REVDAT 2 14-MAR-12 3QTM 1 TITLE REVDAT 1 21-SEP-11 3QTM 0 JRNL AUTH D.RISPAL,J.HENRI,H.VAN TILBEURGH,M.GRAILLE,B.SERAPHIN JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSIS OF NRO1/ETT1: A PROTEIN JRNL TITL 2 INVOLVED IN TRANSLATION TERMINATION IN S. CEREVISIAE AND IN JRNL TITL 3 O2-MEDIATED GENE CONTROL IN S. POMBE JRNL REF RNA V. 17 1213 2011 JRNL REFN ISSN 1355-8382 JRNL PMID 21610214 JRNL DOI 10.1261/RNA.2697111 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 55668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.9069 - 5.8305 0.99 2727 124 0.1765 0.1799 REMARK 3 2 5.8305 - 4.6301 1.00 2687 150 0.1736 0.1844 REMARK 3 3 4.6301 - 4.0454 1.00 2648 147 0.1460 0.1842 REMARK 3 4 4.0454 - 3.6758 1.00 2698 133 0.1489 0.1819 REMARK 3 5 3.6758 - 3.4125 1.00 2646 170 0.1514 0.1861 REMARK 3 6 3.4125 - 3.2114 1.00 2644 149 0.1715 0.1982 REMARK 3 7 3.2114 - 3.0507 1.00 2615 163 0.1842 0.2182 REMARK 3 8 3.0507 - 2.9179 1.00 2681 133 0.1883 0.2566 REMARK 3 9 2.9179 - 2.8056 1.00 2652 159 0.1896 0.2102 REMARK 3 10 2.8056 - 2.7088 1.00 2646 131 0.1905 0.2484 REMARK 3 11 2.7088 - 2.6241 1.00 2696 126 0.1861 0.2370 REMARK 3 12 2.6241 - 2.5491 1.00 2655 130 0.1857 0.2537 REMARK 3 13 2.5491 - 2.4820 1.00 2661 147 0.1827 0.2280 REMARK 3 14 2.4820 - 2.4215 1.00 2651 148 0.1856 0.2275 REMARK 3 15 2.4215 - 2.3664 1.00 2651 131 0.1857 0.2583 REMARK 3 16 2.3664 - 2.3161 1.00 2648 134 0.1841 0.2279 REMARK 3 17 2.3161 - 2.2698 1.00 2688 143 0.1967 0.2676 REMARK 3 18 2.2698 - 2.2269 1.00 2605 152 0.2118 0.2517 REMARK 3 19 2.2269 - 2.1872 1.00 2677 142 0.2149 0.2833 REMARK 3 20 2.1872 - 2.1501 0.86 2265 115 0.2295 0.2803 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 47.12 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06670 REMARK 3 B22 (A**2) : -1.89820 REMARK 3 B33 (A**2) : 1.96500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.39670 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 5424 REMARK 3 ANGLE : 0.910 7383 REMARK 3 CHIRALITY : 0.059 840 REMARK 3 PLANARITY : 0.008 955 REMARK 3 DIHEDRAL : 17.949 1955 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QTM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791, 0.97946, 0.95373 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55704 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46700 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.0, 1.6M AMMONIUM REMARK 280 SULPHATE, 10MM MGCL2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.92000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 48 REMARK 465 GLU A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 THR A 56 REMARK 465 MSE A 57 REMARK 465 LEU A 58 REMARK 465 SER A 304 REMARK 465 GLU A 305 REMARK 465 SER A 306 REMARK 465 ASN A 307 REMARK 465 SER A 392 REMARK 465 ALA A 393 REMARK 465 MSE B 48 REMARK 465 GLU B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 THR B 56 REMARK 465 MSE B 57 REMARK 465 LEU B 58 REMARK 465 VAL B 59 REMARK 465 TYR B 60 REMARK 465 SER B 304 REMARK 465 GLU B 305 REMARK 465 SER B 306 REMARK 465 ASN B 307 REMARK 465 ALA B 393 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 269 23.48 -141.63 REMARK 500 ASP B 84 79.47 -109.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 395 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QTN RELATED DB: PDB DBREF 3QTM A 56 393 UNP Q9USJ7 YJ27_SCHPO 56 393 DBREF 3QTM B 56 393 UNP Q9USJ7 YJ27_SCHPO 56 393 SEQADV 3QTM MSE A 48 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM GLU A 49 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 50 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 51 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 52 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 53 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 54 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS A 55 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM MSE B 48 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM GLU B 49 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 50 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 51 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 52 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 53 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 54 UNP Q9USJ7 EXPRESSION TAG SEQADV 3QTM HIS B 55 UNP Q9USJ7 EXPRESSION TAG SEQRES 1 A 346 MSE GLU HIS HIS HIS HIS HIS HIS THR MSE LEU VAL TYR SEQRES 2 A 346 THR GLU GLU ASP ASN ILE SER GLN LEU TRP GLY LEU TYR SEQRES 3 A 346 GLU MSE SER ARG GLU LYS LEU GLU ASN ASP ASP ILE ASP SEQRES 4 A 346 ALA SER VAL SER LEU VAL PHE GLY THR ILE HIS GLU ALA SEQRES 5 A 346 ASP ARG ILE LEU ARG ASN THR GLU ASP ILE SER THR LEU SEQRES 6 A 346 PRO LYS ASP PHE HIS ALA ALA TYR SER SER ALA LEU LEU SEQRES 7 A 346 ALA VAL SER GLU LEU PHE GLU ILE ALA GLN LYS ARG LEU SEQRES 8 A 346 LYS GLU THR ASN THR GLU GLU SER TYR ILE ASP ALA ALA SEQRES 9 A 346 ILE GLU ARG ALA GLN LEU GLY LEU ASP ALA PRO GLY ASN SEQRES 10 A 346 GLU SER ARG LEU PHE LEU ALA LEU ALA ARG ALA TYR LEU SEQRES 11 A 346 GLU LYS VAL ARG VAL LEU VAL TRP ARG HIS ASP ASN GLU SEQRES 12 A 346 GLU SER LEU ALA ASN ILE PRO VAL THR GLN LEU VAL ASN SEQRES 13 A 346 PRO TYR ILE GLU LYS ALA ILE GLN TYR LEU ARG PRO LEU SEQRES 14 A 346 ALA GLN ASP SER THR GLU TYR PHE ASP ALA LEU THR PRO SEQRES 15 A 346 ASP SER LEU ARG PRO LEU TYR ILE LEU SER SER TYR LEU SEQRES 16 A 346 PHE GLN PHE GLY ASP GLN PHE SER GLU ALA PHE LEU LEU SEQRES 17 A 346 ASP VAL CME SER ILE ILE THR ALA LEU TRP LEU LYS SER SEQRES 18 A 346 VAL VAL ASP PRO ASN THR PRO ALA TYR TYR LYS LEU ILE SEQRES 19 A 346 ALA GLN GLU ALA VAL LEU ASN ASN TYR THR THR PHE ALA SEQRES 20 A 346 GLU TYR TYR MSE ASP LEU LEU ASP ASN SER GLU SER ASN SEQRES 21 A 346 VAL ASP ASP LEU ILE ASN LYS ALA SER SER TRP LEU ASN SEQRES 22 A 346 ASN SER VAL ASP THR TRP ASN VAL ILE TYR THR LEU ASP SEQRES 23 A 346 LYS SER PRO GLU ARG LEU LEU LYS LEU ALA ASP ILE LYS SEQRES 24 A 346 MSE ASP LEU ALA GLN ILE VAL GLN ASP GLU ALA SER GLN SEQRES 25 A 346 ASP ASN TYR LEU LYS GLU ALA CYS ASN ALA ILE LYS GLU SEQRES 26 A 346 ALA GLN GLY SER GLY VAL GLU LEU SER PRO ASP TYR VAL SEQRES 27 A 346 GLU PHE VAL GLU ALA TYR SER ALA SEQRES 1 B 346 MSE GLU HIS HIS HIS HIS HIS HIS THR MSE LEU VAL TYR SEQRES 2 B 346 THR GLU GLU ASP ASN ILE SER GLN LEU TRP GLY LEU TYR SEQRES 3 B 346 GLU MSE SER ARG GLU LYS LEU GLU ASN ASP ASP ILE ASP SEQRES 4 B 346 ALA SER VAL SER LEU VAL PHE GLY THR ILE HIS GLU ALA SEQRES 5 B 346 ASP ARG ILE LEU ARG ASN THR GLU ASP ILE SER THR LEU SEQRES 6 B 346 PRO LYS ASP PHE HIS ALA ALA TYR SER SER ALA LEU LEU SEQRES 7 B 346 ALA VAL SER GLU LEU PHE GLU ILE ALA GLN LYS ARG LEU SEQRES 8 B 346 LYS GLU THR ASN THR GLU GLU SER TYR ILE ASP ALA ALA SEQRES 9 B 346 ILE GLU ARG ALA GLN LEU GLY LEU ASP ALA PRO GLY ASN SEQRES 10 B 346 GLU SER ARG LEU PHE LEU ALA LEU ALA ARG ALA TYR LEU SEQRES 11 B 346 GLU LYS VAL ARG VAL LEU VAL TRP ARG HIS ASP ASN GLU SEQRES 12 B 346 GLU SER LEU ALA ASN ILE PRO VAL THR GLN LEU VAL ASN SEQRES 13 B 346 PRO TYR ILE GLU LYS ALA ILE GLN TYR LEU ARG PRO LEU SEQRES 14 B 346 ALA GLN ASP SER THR GLU TYR PHE ASP ALA LEU THR PRO SEQRES 15 B 346 ASP SER LEU ARG PRO LEU TYR ILE LEU SER SER TYR LEU SEQRES 16 B 346 PHE GLN PHE GLY ASP GLN PHE SER GLU ALA PHE LEU LEU SEQRES 17 B 346 ASP VAL CME SER ILE ILE THR ALA LEU TRP LEU LYS SER SEQRES 18 B 346 VAL VAL ASP PRO ASN THR PRO ALA TYR TYR LYS LEU ILE SEQRES 19 B 346 ALA GLN GLU ALA VAL LEU ASN ASN TYR THR THR PHE ALA SEQRES 20 B 346 GLU TYR TYR MSE ASP LEU LEU ASP ASN SER GLU SER ASN SEQRES 21 B 346 VAL ASP ASP LEU ILE ASN LYS ALA SER SER TRP LEU ASN SEQRES 22 B 346 ASN SER VAL ASP THR TRP ASN VAL ILE TYR THR LEU ASP SEQRES 23 B 346 LYS SER PRO GLU ARG LEU LEU LYS LEU ALA ASP ILE LYS SEQRES 24 B 346 MSE ASP LEU ALA GLN ILE VAL GLN ASP GLU ALA SER GLN SEQRES 25 B 346 ASP ASN TYR LEU LYS GLU ALA CYS ASN ALA ILE LYS GLU SEQRES 26 B 346 ALA GLN GLY SER GLY VAL GLU LEU SER PRO ASP TYR VAL SEQRES 27 B 346 GLU PHE VAL GLU ALA TYR SER ALA MODRES 3QTM MSE A 75 MET SELENOMETHIONINE MODRES 3QTM CME A 258 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3QTM MSE A 298 MET SELENOMETHIONINE MODRES 3QTM MSE A 347 MET SELENOMETHIONINE MODRES 3QTM MSE B 75 MET SELENOMETHIONINE MODRES 3QTM CME B 258 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3QTM MSE B 298 MET SELENOMETHIONINE MODRES 3QTM MSE B 347 MET SELENOMETHIONINE HET MSE A 75 8 HET CME A 258 10 HET MSE A 298 8 HET MSE A 347 8 HET MSE B 75 8 HET CME B 258 10 HET MSE B 298 8 HET MSE B 347 8 HET SO4 A 2 5 HET CL A 1 1 HET EDO A 394 4 HET SO4 B 1 5 HET CL B 2 1 HET EDO B 394 4 HET EDO B 395 4 HETNAM MSE SELENOMETHIONINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 CL 2(CL 1-) FORMUL 5 EDO 3(C2 H6 O2) FORMUL 10 HOH *567(H2 O) HELIX 1 1 THR A 61 ASN A 82 1 22 HELIX 2 2 ASP A 84 THR A 106 1 23 HELIX 3 3 ASP A 108 LEU A 112 5 5 HELIX 4 4 PRO A 113 LEU A 130 1 18 HELIX 5 5 LEU A 130 GLN A 135 1 6 HELIX 6 6 LYS A 136 LEU A 138 5 3 HELIX 7 7 THR A 143 GLY A 158 1 16 HELIX 8 8 LEU A 159 ALA A 161 5 3 HELIX 9 9 GLU A 165 GLU A 190 1 26 HELIX 10 10 PRO A 197 GLN A 218 1 22 HELIX 11 11 PRO A 234 PHE A 245 1 12 HELIX 12 12 GLY A 246 PHE A 249 5 4 HELIX 13 13 SER A 250 SER A 268 1 19 HELIX 14 14 PRO A 275 ASP A 302 1 28 HELIX 15 15 VAL A 308 ASP A 333 1 26 HELIX 16 16 SER A 335 GLU A 337 5 3 HELIX 17 17 ARG A 338 VAL A 353 1 16 HELIX 18 18 ASP A 355 SER A 376 1 22 HELIX 19 19 SER A 381 TYR A 391 1 11 HELIX 20 20 THR B 61 ASN B 82 1 22 HELIX 21 21 ASP B 84 ASN B 105 1 22 HELIX 22 22 ASP B 108 LEU B 112 5 5 HELIX 23 23 PRO B 113 LEU B 130 1 18 HELIX 24 24 LEU B 130 GLN B 135 1 6 HELIX 25 25 LYS B 136 LEU B 138 5 3 HELIX 26 26 THR B 143 GLY B 158 1 16 HELIX 27 27 LEU B 159 ALA B 161 5 3 HELIX 28 28 GLU B 165 GLU B 190 1 26 HELIX 29 29 GLU B 191 ALA B 194 5 4 HELIX 30 30 PRO B 197 ALA B 217 1 21 HELIX 31 31 PRO B 229 ARG B 233 5 5 HELIX 32 32 PRO B 234 PHE B 245 1 12 HELIX 33 33 GLY B 246 PHE B 249 5 4 HELIX 34 34 SER B 250 SER B 268 1 19 HELIX 35 35 PRO B 275 ASN B 303 1 29 HELIX 36 36 VAL B 308 ASP B 333 1 26 HELIX 37 37 GLU B 337 VAL B 353 1 17 HELIX 38 38 ASP B 355 SER B 376 1 22 HELIX 39 39 SER B 381 SER B 392 1 12 LINK C GLU A 74 N MSE A 75 1555 1555 1.32 LINK C MSE A 75 N SER A 76 1555 1555 1.33 LINK C VAL A 257 N CME A 258 1555 1555 1.33 LINK C CME A 258 N SER A 259 1555 1555 1.33 LINK C TYR A 297 N MSE A 298 1555 1555 1.33 LINK C MSE A 298 N ASP A 299 1555 1555 1.33 LINK C LYS A 346 N MSE A 347 1555 1555 1.33 LINK C MSE A 347 N ASP A 348 1555 1555 1.33 LINK C GLU B 74 N MSE B 75 1555 1555 1.33 LINK C MSE B 75 N SER B 76 1555 1555 1.33 LINK C VAL B 257 N CME B 258 1555 1555 1.33 LINK C CME B 258 N SER B 259 1555 1555 1.33 LINK C TYR B 297 N MSE B 298 1555 1555 1.33 LINK C MSE B 298 N ASP B 299 1555 1555 1.33 LINK C LYS B 346 N MSE B 347 1555 1555 1.33 LINK C MSE B 347 N ASP B 348 1555 1555 1.33 SITE 1 AC1 3 ARG A 101 ARG A 104 ASN A 105 SITE 1 AC2 2 ALA A 276 HOH A 470 SITE 1 AC3 3 TRP A 70 HOH A 597 HOH A 627 SITE 1 AC4 3 ARG B 101 ARG B 104 ASN B 105 SITE 1 AC5 5 ARG B 167 PHE B 224 ASP B 225 HOH B 400 SITE 2 AC5 5 HOH B 445 SITE 1 AC6 3 PHE A 93 HIS A 97 GLU B 191 CRYST1 48.930 107.840 101.790 90.00 102.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020437 0.000000 0.004452 0.00000 SCALE2 0.000000 0.009273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010055 0.00000